Cancer drug setback hits Antisoma Health / Medicine Related News
Shares in Antisoma fell almost 71 per cent following news that one of its key cancer drugs did not prolong life in humans Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,